Physician profile
Michael R Schuck
NPI 1780609289
$6,125.61
in general payments reported to CMS, 2019-2025
14 companies · $2,428 in 2025
The $2,428 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $64.84 · 2022: $484 · 2023: $1,175 · 2024: $1,974 · 2025: $2,428.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,897 · Food and Beverage: $2,680.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,896.51 |
| Food and Beverage | $2,680.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $4,958.17 | 2019-2025 | Ri Hip Navigation, Journey II, Journey |
| Stryker Corporation | $328.37 | 2023-2025 | Mako, Triathlon, Iconix |
| Zimmer Biomet Holdings, INC. | $287.45 | 2025 | Persona |
| Avanos Medical | $264.23 | 2023-2025 | On-Q* Pump and Accessories, On-Q Pump and Accessories |
| Orthofix Medical, INC. | $65.21 | 2022 | |
| International Life Sciences | $46.00 | 2024 | Flexband |
| Medacta USA, INC. | $33.86 | 2025 | Nextar Rsa Platform |
| Fidia Pharma USA INC. | $27.25 | 2022 | |
| Heraeus Medical, LLC. | $26.69 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $25.48 | 2024 | Iovera, Zilretta, Exparel |
| Biocomposites INC | $17.45 | 2023 | Stimulan |
| Ferring Pharmaceuticals INC. | $15.89 | 2024 | Euflexxa |
| Depuy Synthes Sales INC. | $15.08 | 2024 | Monovisc, Orthovisc |
| Linvatec Corporation | $14.48 | 2024 | Biobrace 23mm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Schuck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.